Bladder Neck Contracture (BNC)
Bladder neck contracture (BNC) is stenosis of the bladder neck after benign prostate surgery, such as TURP or HoLEP. EAU reports bladder neck stenosis in 0.3–9.7% of transurethral prostate surgery, and it is more frequent after resection of smaller glands and with excessive or circumferential resection.[1] Post-prostatectomy VUAS involves a different anastomosis and remaining sphincter anatomy. Select treatment by lumen, length, prior procedures or radiation, bladder function, continence and patient goals.[1] The AUA 2023 amendment states that surgeons may perform dilation, bladder neck incision, or transurethral resection for BNC after an endoscopic prostate procedure .[2] For recalcitrant bladder-neck stenosis, surgeons may perform robotic or open reconstruction .[2] It notes that no studies compare treatment strategies for BNC after endoscopic prostate procedures and that repeat endoscopic treatment may be necessary.[2]
Decision framework
| Clinical situation | Main considerations |
|---|---|
| Nonobliterative post-BPO BNC | EAU recommends transurethral resection or hot-knife incision as first-line treatment for nonobliterative post-BPO BNS . In a retrospective resection cohort, 35/60 (58.3%) men with BNS after endoscopic benign prostate surgery had no instrument-requiring recurrence across patients who had undergone one or more TURs; the combined BNS/VUAS cohort had mean 27.1-month follow-up. In a separate mixed-cohort incision series (74% VUAS), 36/50 (72%) required no further obstruction surgery at mean 12.9 months.[1][4][13] A mixed-etiology series of 123 patients, 76 of whom had undergone radical prostatectomy with or without radiation, used 24 Fr balloon dilation followed by deep 3 and 9 o’clock Collins-knife incisions. Using 16 Fr cystoscope passage at about two months as its success criterion, it reported 101/123 (82.1%) after one procedure and 116/123 (94.3%) after two at median 12-month follow-up; two or more prior endoscopic treatments were associated with failure.[3] In a separate 372-man post-TURP incision cohort, 29/372 (7.8%) had recurrent BNS and 64/372 (17.2%) had postoperative incontinence, mostly lasting no more than three months; baseline continence was not available.[9] |
| Recurrent but patent lumen | Repeat endoluminal treatment is recommended to stabilize the stenosis (weak).[1] In a 50-patient mixed cohort of deep lateral incisions (74% VUAS and 26% BNS in the EAU evidence table), 72% needed no further surgery for obstruction at mean 12.9 months and 86% overall after up to two incisions (7 of 14 initial failures had a successful repeat incision); more than 10 pack-years of smoking and two or more previous endoscopic procedures were associated with failure.[1][4] Repeated recurrence or unacceptable treatment burden warrants a discussion of reconstruction, and there is no fixed two-failure rule |
| Refractory to endoscopic treatment | EAU recommends bladder-neck reconstruction with Y-V or T-plasty , citing patency of 83–100% and de novo incontinence of 0–14%, and it recommends warning patients about de novo incontinence .[1] A 2026 review of 33 heterogeneous reconstruction studies (667 patients) reported pooled BNS patency of 92% in robotic cohorts (n = 95) and 92% in open cohorts (n = 83); these are not Y-V-specific or head-to-head estimates. It also reported complications in 36% of 61 robotic BNS cases, with heterogeneous definitions and follow-up.[10] In an open Y-V plasty series of 18 men after TURP with two or more failed endoscopic treatments, 18/18 required no further indwelling catheterization, dilation, urethrotomy or open surgery at mean 14.8-month follow-up; 61% reported persistent storage symptoms.[5] See Y-V plasty, T-plasty, primary reanastomosis and subtrigonal BMG inlay |
| Complete obliteration | EAU advises against endoluminal treatment . Assess reconstructive access, tissue availability and drainage alternatives.[1] |
| Concurrent SUI | Establish stable patency and assess bladder and sphincter function before continence surgery. EAU discusses a three- to four-month interval and cystoscopic exclusion of recurrence before continence surgery after posterior DVIU. Its three- to six-month AUS interval concerns ReDo VUAS reconstruction.[1] In 63 men referred with BNC after radical prostatectomy (a different population from post-BPO BNC), deep cold-knife incision was followed by cystoscopic reassessment at 3–4 months; 33 men underwent an AUS or male sling according to continence level once the BNC was stable. Of the 46 men with successful BNC management, 91.3% were satisfied with continence, and 66% overall achieved continence.[6] |
| Orthotopic neobladder BNC | In 71 men without prior radiation who had BNC in an orthotopic neobladder, 155 endoscopic procedures had a per-procedure success of 37% (50/136 after excluding 19 with inadequate follow-up), defined as no additional surgery with at least one year of follow-up; the rate did not fall with repeated treatment. Success was 58% (14/24) with adjuvant clean intermittent catheterization and 32% (36/112) without (p = 0.02). Overall, the authors reported a successful outcome in 50 of 71 patients; two needed neobladder removal.[7] |
| Radiation, necrosis or fistula | Reassess tissue viability and bladder salvageability. After pelvic cancer therapy, prior radiation or failed reconstruction can complicate repair, especially with dense fibrosis, necrosis, calcification, fistula, refractory incontinence, poor bladder function or severe comorbidity. Diversion with or without cystectomy is a last-resort option when reconstruction is infeasible or futile.[8] |
| Devastated outlet | Consider chronic suprapubic drainage, selected bladder-neck closure with a dependable alternate route such as a catheterizable channel, or diversion, according to bladder function and goals |
For VUAS or radiation-induced bulbomembranous stenosis, avoid deep incisions at six and 12 o’clock because of rectal injury and urosymphyseal fistula risk .[1] EAU advises against mitomycin C for posterior stenosis outside a clinical trial after grade 3 complications in 4/55 patients, including osteitis pubis, bladder-neck necrosis and rectourethral fistula; three ultimately required diversion. It recommends against posterior urethral stents .[1] The Optilume urethral drug-coated balloon is labeled for anterior urethral strictures, so use for BNC is off-label. Its IFU contraindicates known hypersensitivity to paclitaxel or structurally related compounds and urologic implants such as penile implants or artificial urinary sphincters; it warns against treatment during active UTI. Men should abstain from sex or use a condom for 30 days and, if a partner can conceive, use highly effective contraception and avoid fathering children for at least six months.[11] Novel graft or mucosal-realignment procedures are not established first-line replacements.[1]
The initial TUITMR series included 19 patients with mixed BNC/VUAS and defined success by 17 Fr flexible cystoscope passage at four-month cystoscopy; 17/19 met this endpoint after one procedure and 19/19 after a second, with median follow-up of six months.[14] In the T-plasty series, 27/30 post-BPO patients were evaluable after three were lost to follow-up; the authors reported 100% success at median 45 months.[15] A later retrospective TUITMR registry of 92 men with BNC after benign prostate surgery reported 93.5% cystoscopic patency and 83.7% freedom from reintervention after one procedure at a median follow-up of 15.9 months; it did not compare TUITMR with standard incision or reconstruction.[12] Patency, dryness and freedom from additional procedures are different endpoints. EAU gives a weak recommendation to warn patients about the risk of new or worsened urinary incontinence after endoluminal treatment for non-traumatic posterior stenosis.[1]
Treatment Database
| Technique | Tier | Evidence / reported outcome | Clinical use |
|---|---|---|---|
| Transurethral Incision of BNC (TUIBNC) | Endoscopic — First-Line | 16 Fr cystoscope passage at about 2 mo: 101/123 after one; 116/123 after two (mixed BNC/VUAS; median follow-up 12 mo) [3] | Nonobliterative BNC; see anatomy, depth and continence precautions. |
| Transurethral Bladder Neck Resection (TURBN) | Endoscopic — First-Line | Observational evidence; see detailed technique | Nonobliterative post-BPO BNC suitable for controlled loop resection. |
| Balloon Dilation for BNC | Endoscopic — Selected Option | Balloon-only and combined-incision outcomes differ | Selected nonobliterative disease or access before incision; posterior DCB use is off-label. |
| Transurethral Incision with Transverse Mucosal Realignment (TUITMR) | Endoscopic — Adjunct / Novel | 17/19 initial; 19/19 after repeat, median 6 mo | Evolving endoscopic mucosal-realignment option; mixed BNC/VUAS index cohort. |
| Y-V Plasty (Robotic / Open) | Reconstruction — Robotic | Selected observational cohorts | Refractory stenosis with viable bladder tissue that can reach the opened outlet without tension. |
| Robotic Subtrigonal BMG Inlay | Reconstruction — Robotic | Single post-BPH BNC case report | Specialist graft augmentation; distinct from perineal dorsal onlay. |
| Robotic Bladder Flap Posterior Urethroplasty | Reconstruction — Robotic | 7/9 without recurrence, mean 21.1 wk | Selected mixed BNC/VUAS defects requiring a new flap-based anastomosis. |
| Transvesical RARP for Recalcitrant BNC | Reconstruction — Robotic | 8 selected post-HoLEP cases; minimum 6 mo | Exceptional salvage with remaining prostate tissue; not routine BNC treatment. |
| T-Plasty | Reconstruction — Open | 27/27 evaluable of 30, median 45 mo | Selected recurrent post-BPO BNC; one center with overlapping reports. |
| Tanagho Flap | Reconstruction — Open | Historical heterogeneous series | Bladder-tube reconstruction for selected outlet/urethral loss; not routine post-BPO BNC. |
| Salvage Prostatectomy (Reconstructive) | Reconstruction — Open | Highly selected salvage cohorts | An unsalvageable remaining prostate in complex outlet disease; abscess alone does not mandate prostatectomy. |
| Bladder Neck Closure | Continence-Creating Outlet | Closure, continence and revision are separate outcomes | Selected devastated outlet with permanent SPT or another dependable drainage route. |
| Permanent Suprapubic Catheter | Salvage / Diversion | Drainage option | Temporary or long-term drainage according to reconstruction suitability and patient goals. |
| Continent Catheterizable Channel (Mitrofanoff) | Salvage / Diversion | Catheterizable access; long-term revision risk | Selected patients with safe storage and reliable catheterization; outlet closure/augmentation only when indicated. |
| Urinary Diversion ± Cystectomy | Salvage / Diversion | Individual reconstruction-specific outcomes | Unsuitable bladder/outlet or unacceptable further reconstructive burden; choose with the patient. |
Videos
References
1. European Association of Urology. EAU Guidelines on Urethral Strictures. 2026. Disease management in males, sections 6.3.5–6.3.6. Guideline.
2. Wessells H, Morey A, Souter L, Rahimi L, Vanni A. "Urethral Stricture Disease Guideline Amendment (2023)." The Journal of Urology. 2023;210(1):64-71. doi:10.1097/JU.0000000000003482
3. Nealon SW, Bhanvadia RR, Badkhshan S, et al. "Transurethral Incisions for Bladder Neck Contracture: Comparable Results Without Intralesional Injections." Journal of Clinical Medicine. 2022;11(15):4355. doi:10.3390/jcm11154355
4. Ramirez D, Zhao LC, Bagrodia A, et al. "Deep Lateral Transurethral Incisions for Recurrent Bladder Neck Contracture: Promising 5-Year Experience Using a Standardized Approach." Urology. 2013;82(6):1430-5. doi:10.1016/j.urology.2013.08.018
5. Shamout S, Yao HHI, Mossa AH, Carlson KV, Baverstock RJ. "Persistent Storage Symptoms Following Y-V Plasty Reconstruction for the Treatment of Refractory Bladder Neck Contracture." Neurourology and Urodynamics. 2022;41(5):1082-1090. doi:10.1002/nau.24941
6. Brede C, Angermeier K, Wood H. "Continence Outcomes After Treatment of Recalcitrant Postprostatectomy Bladder Neck Contracture and Review of the Literature." Urology. 2014;83(3):648-652. doi:10.1016/j.urology.2013.10.042
7. Pariser JJ, Saltzman GB, Bales GT, Steinberg GD, Smith ND. "Outcomes of the Endoscopic Treatment of Bladder Neck Contractures in the Orthotopic Neobladder." Urology. 2015;86(3):613-617. doi:10.1016/j.urology.2015.06.020
8. Martins FE, Holm HV, Lumen N. "Devastated Bladder Outlet in Pelvic Cancer Survivors: Issues on Surgical Reconstruction and Quality of Life." Journal of Clinical Medicine. 2021;10(21):4920. doi:10.3390/jcm10214920
9. Castellani D, Stramucci S, Enganti B, et al. "One-year outcomes of transurethral treatment of bladder neck stenosis following transurethral resection of the prostate: Results from a large, multicenter series." Int J Gen Med. 2024;17:1967-1974. doi:10.2147/IJGM.S459441
10. Roessler N, Klemm J, Fisch M, Dahlem R, Vetterlein MW; Trauma and Reconstructive Urology Working Party of the European Association of Urology Young Academic Urologists. "A systematic review and meta-analysis of surgical reconstruction for bladder neck and vesicourethral anastomotic stenosis: The case for etiology-specific definitions and reporting." Eur Urol Focus. 2026;12(3):360-372. doi:10.1016/j.euf.2026.06.012
11. Urotronic. Optilume Urethral Drug Coated Balloon Catheter: Instructions for Use. Document 1111-003, Rev A. FDA labeling.
12. Curtis J, Schrup S, Moring N, et al. "Transurethral Incision With Transverse Mucosal Realignment for the Treatment of Bladder Neck Contractures After Benign Prostate Surgery; Mid-term Outcomes." Urology. Published online July 16, 2026. doi:10.1016/j.urology.2026.07.018
13. Kranz J, Reiss PC, Salomon G, Steffens J, Fisch M, Rosenbaum CM. "Differences in Recurrence Rate and De Novo Incontinence after Endoscopic Treatment of Vesicourethral Stenosis and Bladder Neck Stenosis." Front Surg. 2017;4:44. doi:10.3389/fsurg.2017.00044
14. Abramowitz DJ, Balzano FL, Ruel NH, Chan KG, Warner JN. "Transurethral Incision With Transverse Mucosal Realignment for the Management of Bladder Neck Contracture and Vesicourethral Anastomotic Stenosis." Urology. 2021;152:102-108. doi:10.1016/j.urology.2021.02.035
15. Rosenbaum CM, Dahlem R, Maurer V, et al. "The T-plasty as therapy for recurrent bladder neck stenosis: success rate, functional outcome, and patient satisfaction." World J Urol. 2017;35(12):1907-1911. doi:10.1007/s00345-017-2089-2